AKA: Corn lily False hellebore Skunk cabbage Family Liliaceae Native to mountain meadows in the Sierra Nevadas and the Rockies
Perennial monocot Grows 1-2 meters tall Stem/leaves resemble cornstalk
Used by native Americans to treat wounds Contraceptive Root is an analgesic and disinfectant Also used to treat VD
Sheep herds were plagued by unexplained birth defects Intensive study by the USDA isolated cyclopamine as the causative agent
Required for tissue maintenance and regeneration T-cell activation Can act as a mitogen Tissue dependent
GPCRs (G Protein Coupled Receptor) are responsible for a multitude of signal cascades : 1. Adenylate cyclase/cAMP pathway Activates PKA, which activates ion channels 2. Phospholipase C pathway Secretion and translocation of proteins from the ER 3. IP 3 pathway: Releases Ca+ from ER activating 4. Ca+/Calmodulin pathway 5. Glycogen pathway (via Adenylate cyclase)
Phase I clinical trials underway of a derivate GDC-0449 (Genentech in collaboration with Curis) Preliminary results were promising Side effects: loss of hair, weight loss, otherwise mild toxicity reported Already being billed as “hav[ing] the potential to become a blockbuster drug…for treating cancers.” (Wong, 2009)
Glioblastoma multiforme (brain tumor) 2-3 cases per 100K Most often terminal Median survival = 15 months (conventional chemotherapy) Without treatment = 4.5 months (World Heath Organization)
Synthetic drug marketed as a sedative Prescribed to pregnant women to help with morning sickness Drug testing conducted on rats Rats metabolized thalidomide Late 1950’s children born with Pharcomelia Later tests on monkeys produced same birth defects as seen in humans
Berry, L. (n.d.). Sierra Wild Flowers. Retrieved Oct 23, 2009, from Sierrawildflowers.org: Binns, W. L. (1968). Effects of Teratogenic Agents in Range Plants. Cancer Research, 28, Keeley. (2002). Biology News. Retrieved Oct 23, 2009, from Bio- Medicine: compound-kills-brain-tumor-cells / Lingham, A. (2000, June). The First Appearance of Thalidomide. Retrieved Oct 23, 2009, from Thalidomide Isomerism and Optical Isomerism: Wong, J. F. (2009). Genetic Engineering & Biotechnology News. Retrieved Oct 23, 2009, from GEN: hid=4